Novel Peptide-Based Inhibitors of Protein Kinases

作者: Justin M. Holub

DOI: 10.1007/978-3-030-48283-1_8

关键词:

摘要: Protein kinases are a class of enzymes that modulate the function and activity other proteins through phosphorylation. regulate many aspects cellular metabolism including signal transduction, transcription, translation, cell-cycle progression, biosynthesis. Owing to their profound influence over such critical processes, mutations or aberrant expression protein can have major implications on cell health viability. Indeed, dysfunctional kinase has been linked pathological conditions as neurodegeneration, inflammation, autoimmunity, cancer. Despite therapeutic importance, our ability target discrete using small-molecule-based inhibitors hindered due high degrees structural similarity among active sites. Recently, peptides emerged powerful, yet selective, modulators by virtue mimic highly specific substrate-interaction domains kinases. This chapter provides an overview development application novel peptide-based inhibitors. The goal here is highlight how various binding modes efforts enhance affinities contributed understanding complex nature kinase–substrate interactions. Furthermore, relevance explored, focusing advantages limitations molecules they applied in treatment kinase-mediated disease.

参考文章(125)
Peter D. Mace, Yann Wallez, Michael F. Egger, Małgorzata K Dobaczewska, Howard Robinson, Elena B. Pasquale, Stefan J. Riedl, Structure of ERK2 bound to PEA-15 reveals a mechanism for rapid release of activated MAPK. Nature Communications. ,vol. 4, pp. 1681- 1681 ,(2013) , 10.1038/NCOMMS2687
Fei Liu, Cheng-Xin Gong, Alejandra del C. Alonso, Inge Grundke-Iqbal, Khalid Iqbal, Mechanisms of tau-induced neurodegeneration Acta Neuropathologica. ,vol. 118, pp. 53- 69 ,(2009) , 10.1007/S00401-009-0486-3
Alexandra C. Newton, Protein Kinase C: Structure, Function, and Regulation Journal of Biological Chemistry. ,vol. 270, pp. 28495- 28498 ,(1995) , 10.1074/JBC.270.48.28495
J. Zheng, E. A. Trafny, D. R. Knighton, N. Xuong, S. S. Taylor, L. F. Ten Eyck, J. M. Sowadski, 2.2 A refined crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with MnATP and a peptide inhibitor. Acta Crystallographica Section D-biological Crystallography. ,vol. 49, pp. 362- 365 ,(1993) , 10.1107/S0907444993000423
Hagit Eldar-Finkelman, Miriam Eisenstein, Peptide inhibitors targeting protein kinases. Current Pharmaceutical Design. ,vol. 15, pp. 2463- 2470 ,(2009) , 10.2174/138161209788682253
Sinu Paul, Ravi V. Kolla, John Sidney, Daniela Weiskopf, Ward Fleri, Yohan Kim, Bjoern Peters, Alessandro Sette, Evaluating the Immunogenicity of Protein Drugs by Applying In Vitro MHC Binding Data and the Immune Epitope Database and Analysis Resource Clinical & Developmental Immunology. ,vol. 2013, pp. 467852- 467852 ,(2013) , 10.1155/2013/467852
Carlos J. Camacho, Yasuhiro Katsumata, Dana P. Ascherman, Structural and Thermodynamic Approach to Peptide Immunogenicity PLoS Computational Biology. ,vol. 4, pp. e1000231- ,(2008) , 10.1371/JOURNAL.PCBI.1000231
Mazen W Karaman, Sanna Herrgard, Daniel K Treiber, Paul Gallant, Corey E Atteridge, Brian T Campbell, Katrina W Chan, Pietro Ciceri, Mindy I Davis, Philip T Edeen, Raffaella Faraoni, Mark Floyd, Jeremy P Hunt, Daniel J Lockhart, Zdravko V Milanov, Michael J Morrison, Gabriel Pallares, Hitesh K Patel, Stephanie Pritchard, Lisa M Wodicka, Patrick P Zarrinkar, A quantitative analysis of kinase inhibitor selectivity. Nature Biotechnology. ,vol. 26, pp. 127- 132 ,(2008) , 10.1038/NBT1358